Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build Kenya flag

Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions

CodeSystem: Kenya Medication Clinical Category Code System

Official URL: https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs Version: 0.1.0
Active as of 2026-06-04 Computable Name: MedClinicalCategoryCS

Codes classifying the clinical role of a medication within an oncology regimen.

This Code system is referenced in the definition of the following value sets:

This case-sensitive code system https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs defines the following codes:

CodeDisplayDefinition
CHEMOTHERAPY Chemotherapy Cytotoxic agent used to kill or inhibit cancer cells.
IMMUNOTHERAPY Immunotherapy Agent that stimulates the immune system against cancer.
TARGETED-THERAPY Targeted Therapy Agent targeting specific molecular markers on cancer cells.
HORMONAL-THERAPY Hormonal Therapy Agent that blocks or modifies hormone-driven tumour growth.
SUPPORTIVE-CARE Supportive Care Medication to manage side effects or improve tolerability.
ANTI-EMETIC Anti-emetic Agent to prevent or treat nausea and vomiting.
GROWTH-FACTOR Growth Factor Colony-stimulating factor to support blood cell recovery.
CORTICOSTEROID Corticosteroid Steroid given as part of or to support the oncology regimen.
BISPHOSPHONATE Bisphosphonate Agent for prevention or treatment of bone metastasis.
ANALGESIC Analgesic Pain management medication in the cancer care context.

Description of the above table(s).